FE PHARMA TECH<00399> - Results Announcement
Far East Pharmaceutical Technology Co., Limited announced on 26/03/2004:
(stock code: 00399 )
Year end date: 30/06/2004
Currency: HKD
Auditors' Report: N/A
Interim report reviewed by: Audit Committee
(Unaudited )
(Unaudited ) Last
Current Corresponding
Period Period
from 01/07/2003 from 01/07/2002
to 31/12/2003 to 31/12/2002
Note ('000 ) ('000 )
Turnover : 559,525 458,656
Profit/(Loss) from Operations : 165,549 121,691
Finance cost : (3,844) N/A
Share of Profit/(Loss) of
Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : N/A N/A
Profit/(Loss) after Tax & MI : 120,387 87,665
% Change over Last Period : +37.33 %
EPS/(LPS)-Basic (in dollars) : 0.059 0.0431
-Diluted (in dollars) : 0.056 0.0419
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : 120,387 87,665
Interim Dividend : NIL NIL
per Share
(Specify if with other : N/A N/A
options)
B/C Dates for
Interim Dividend : N/A
Payable Date : N/A
B/C Dates for (-)
General Meeting : N/A
Other Distribution for : N/A
Current Period
B/C Dates for Other
Distribution : N/A
Remarks:
EARNINGS PER SHARE
The calculation of basic and fully diluted earnings per share is based on
the net profit from ordinary activity of the Group attributable to
shareholders of HK$120,387,000 (2002: HK$87,665,000) and the weighted
average number of ordinary shares in issued during the period of
2,039,764,139 shares (2002: 2,035,728,000 shares after adjusted for the
effect of the share subdivision).
The calculation of fully diluted earnings per share is based on the
weighted average number of ordinary shares in issue during the period of
2,039,764,139 shares (2002: 2,035,728,000 shares after adjusted for the
effect of share subdivision) plus the weighted average of ordinary shares
deemed to be issued at no consideration of 110,293,561 shares (2002:
56,181,628 shares after adjusted for the effect of share subdivision) if
all outstanding options have been exercised.
|
